Edesa Biotech Inc.

Edesa Biotech Inc. could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. Tradey thinks it is not wise to invest in Edesa Biotech Inc..
Log in to see more information.

News

HC Wainwright Weighs in on Edesa Biotech, Inc.'s FY2024 Earnings (NASDAQ:EDSA)
HC Wainwright Weighs in on Edesa Biotech, Inc.'s FY2024 Earnings (NASDAQ:EDSA)

Ticker Report Edesa Biotech, Inc. (NASDAQ:EDSA - Free Report) - HC Wainwright boosted their FY2024 earnings per share estimates for Edesa Biotech in a note issued to investors on Tuesday, August 20th. HC...\n more…

Edesa Biotech, Inc. Forecasted to Earn FY2024 Earnings of ($2.04) Per Share (NASDAQ:EDSA)
Edesa Biotech, Inc. Forecasted to Earn FY2024 Earnings of ($2.04) Per Share (NASDAQ:EDSA)

Ticker Report Edesa Biotech, Inc. (NASDAQ:EDSA - Free Report) - Equities research analysts at Zacks Small Cap dropped their FY2024 earnings per share (EPS) estimates for shares of Edesa Biotech in a research note...\n more…

Edesa Biotech (NASDAQ:EDSA) Given Buy Rating at HC Wainwright
Edesa Biotech (NASDAQ:EDSA) Given Buy Rating at HC Wainwright

Zolmax HC Wainwright reaffirmed their buy rating on shares of Edesa Biotech (NASDAQ:EDSA - Free Report) in a research report report published on Tuesday, Benzinga reports. HC Wainwright currently has a...\n more…

Edesa Biotech (NASDAQ:EDSA) Earns "Buy" Rating from HC Wainwright
Edesa Biotech (NASDAQ:EDSA) Earns "Buy" Rating from HC Wainwright

Ticker Report Edesa Biotech (NASDAQ:EDSA - Get Free Report)s stock had its "buy" rating restated by equities researchers at HC Wainwright in a report issued on Tuesday, Benzinga reports. They currently have...\n more…

EDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nEDSA stock results show that Edesa Biotech beat analyst estimates for earnings per share the third quarter of 2024.\nThe post EDSA Stock...\n more…

Edesa Biotech Showcases Steady Q3 2024 Financials
Edesa Biotech Showcases Steady Q3 2024 Financials

TipRanks Financial Blog Edesa Biotech (EDSA) has released an update. Edesa Biotech, a clinical-stage biopharmaceutical company, has announced its third-quarter financials for 2024, reveali...\n more…